Back to today’s briefing

Story perspectives

Study Reveals Blood Markers for Cannabis-Linked Schizophrenia Risk

3/22/2025

46 6

Summary

Story summary

Researchers at the University of the Basque Country have uncovered unique metabolic signatures in blood that may reveal why cannabis affects some users differently, potentially leading to schizophrenia. Their groundbreaking study, featured in Scientific Reports, highlights specific fatty acids as promising biomarkers, offering hope for tailored risk assessments in cannabis-related psychiatric disorders.

1 of 1

Story summary

Researchers at the University of the Basque Country have uncovered unique metabolic signatures in blood that may reveal why cannabis affects some users differently, potentially leading to schizophrenia. Their groundbreaking study, featured in Scientific Reports, highlights specific fatty acids as promising biomarkers, offering hope for tailored risk assessments in cannabis-related psychiatric disorders.